PR Newswire Europe - Xeloda Filed in Europe for Treatment of Advanced Stomach Cancer.
July 21, 2006 -- BASEL, Switzerland, July 21 /PRNewswire/ -- - Oral Cancer Drug Offers Patients With Stomach Cancer A Highly Effective and Safe Treatment Option...
Chain Drug Review - Xeloda approved
June 4, 2001 -- Hoffmann-La Roche Inc. will roll out Xeloda, an oral chemotherapy for the treatment of metastatic colorectal cancer, the second-leading cause of...
PR Newswire Europe - Benefits of Oral Xeloda Over Continuous Intravenous Chemotherapy Confirmed for Advanced Stomach Cancer.
January 7, 2008 -- BASEL, Switzerland, January 7 /PRNewswire/ -- - For non US or non UK Media Only - Oral Chemotherapy Tablet Option Reduces the Time Patients...
PR Newswire Europe - Xeloda Should Replace Burdensome Intravenous Chemotherapy.
May 17, 2005 -- BASEL, Switzerland, May 17 /PRNewswire/ -- - New data presented at ASCO confirm Xeloda as the smart chemotherapy choice for colon cancer...
PR Newswire Europe - New Xeloda Combination Allows Patients with Stomach Cancer to Live Significantly Longer.
June 5, 2006 -- BASEL, Switzerland, June 5 /PRNewswire/ -- - In Addition, Oral Chemotherapy Xeloda Reduces Treatment Time for Patients Results of the...
PR Newswire Europe - New Breast Cancer Data Show Xeloda is as Effective as Anthracyclines in Combination with Paclitaxel.
June 4, 2006 -- BASEL, Switzerland, June 4 /PRNewswire/ -- - Xeloda plus paclitaxel is a new, safer first-line treatment option for patients with advanced...
PR Newswire Europe - Review Publication Confirms the Benefits of Highly Effective Oral Cancer Drug Xeloda(R) (capecitabine) Over Intravenous Chemotherapy in Advanced Breast Cancer.
November 20, 2007 -- BASEL, Switzerland, November 20 /PRNewswire/ -- - Annals of Oncology Paper Suggests That Oral Agents Such as Xeloda, Which are Proven to be...
Pharmaceutical Processing - FDA approves TYKERB[R] in combination with Xeloda[R] for breast cancer.(Industry News)
April 1, 2007 -- GlaxoSmithKline recently announced that the FDA has approved TYKERB[R] (lapatinib), in combination with Xeloda[R] (capecitabine), for the treatment...
PR Newswire Europe - Smart Pill Xeloda Now Shown to Extend Survival for Patients With Pancreatic Cancer.
November 2, 2005 -- BASEL, Switzerland, November 2 /PRNewswire/ -- - First Xeloda data to show survival benefit in this deadly cancer The interim analysis of one...
PR Newswire Europe - Xeloda Meets Primary Endpoint in Multinational Phase III Advanced Colorectal Cancer Study.
December 11, 2006 -- BASEL, Switzerland, December 11 /PRNewswire/ -- - Roche to Approach World-Wide Regulatory Authorities for a New File Submission Roche...
